[DNLI] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
08-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -11.25%
YoY- -71.69%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue -305,043 1,267 294,123 35,141 10,283 3,559 52,480 -
PBT -119,443 -99,353 183,383 -109,781 -98,684 -103,299 -58,767 60.24%
Tax 30 2,257 -2,285 -10,047 -6 2,114 27 7.25%
NP -119,473 -99,353 183,383 -109,781 -98,678 -103,299 -58,794 60.22%
Tax Rate - - 1.25% - - - - -
Total Cost -185,570 100,620 110,740 144,922 108,961 106,858 111,274 -
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 39.17 -7,841.59 62.35 -312.40 -959.62 -2,902.47 -112.03 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.86 -0.72 1.34 -0.80 -0.74 -0.84 -0.48 47.35%
EPS Diluted -0.86 -0.72 1.30 -0.80 -0.74 -0.84 -0.48 47.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.